Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro.
Biology
Richtig, Georg G; Kienzl, Melanie M; Rittchen, Sonja S; Roula, David D; Eberle, Jürgen J; Sarif, Zina Z; Pichler, Martin M; Hoefler, Gerald G; Heinemann, Akos A
Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma.
Life Science Alliance
Romano, David D; García-Gutiérrez, Lucía L; Aboud, Nourhan N; Duffy, David J DJ; Flaherty, Keith T KT; Frederick, Dennie T DT; Kolch, Walter W; Matallanas, David D
Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway.
Frontiers In Pharmacology
Wang, Lei L; Otkur, Wuxiyar W; Wang, Aman A; Wang, Wen W; Lyu, Yitong Y; Fang, Lei L; Shan, Xiu X; Song, Mingzhou M; Feng, Yan Y; Zhao, Yi Y; Piao, Hai-Long HL; Qi, Huan H; Liu, Ji-Wei JW
CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways.
Saudi Journal Of Biological Sciences
Al Shahrani, Mesfer M; Rajagopalan, Prasanna P; Abohassan, Mohammad M; Alshahrani, Mohammad M; Alraey, Yasser Y
DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF.
Life Science Alliance
Gutierrez-Prat, Nuria N; Zuberer, Hedwig L HL; Mangano, Luca L; Karimaddini, Zahra Z; Wolf, Luise L; Tyanova, Stefka S; Wellinger, Lisa C LC; Marbach, Daniel D; Griesser, Vera V; Pettazzoni, Piergiorgio P; Bischoff, James R JR; Rohle, Daniel D; Palladino, Chiara C; Vivanco, Igor I
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy.
Science Advances
Ng, Thomas S C TSC; Hu, Huiyu H; Kronister, Stefan S; Lee, Chanseo C; Li, Ran R; Gerosa, Luca L; Stopka, Sylwia A SA; Burgenske, Danielle M DM; Khurana, Ishaan I; Regan, Michael S MS; Vallabhaneni, Sreeram S; Putta, Niharika N; Scott, Ella E; Matvey, Dylan D; Giobbie-Hurder, Anita A; Kohler, Rainer H RH; Sarkaria, Jann N JN; Parangi, Sareh S; Sorger, Peter K PK; Agar, Nathalie Y R NYR; Jacene, Heather A HA; Sullivan, Ryan J RJ; Buchbinder, Elizabeth E; Mikula, Hannes H; Weissleder, Ralph R; Miller, Miles A MA
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma.
International Journal Of Molecular Sciences
Fattore, Luigi L; Campani, Virginia V; Ruggiero, Ciro Francesco CF; Salvati, Valentina V; Liguoro, Domenico D; Scotti, Lorena L; Botti, Gerardo G; Ascierto, Paolo Antonio PA; Mancini, Rita R; De Rosa, Giuseppe G; Ciliberto, Gennaro G
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts.
Cell Reports
Kemper, Kristel K; Krijgsman, Oscar O; Kong, Xiangjun X; Cornelissen-Steijger, Paulien P; Shahrabi, Aida A; Weeber, Fleur F; van der Velden, Daphne L DL; Bleijerveld, Onno B OB; Kuilman, Thomas T; Kluin, Roel J C RJC; Sun, Chong C; Voest, Emile E EE; Ju, Young Seok YS; Schumacher, Ton N M TNM; Altelaar, A F Maarten AFM; McDermott, Ultan U; Adams, David J DJ; Blank, Christian U CU; Haanen, John B JB; Peeper, Daniel S DS
Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.
Oncogene
Bianchi-Smiraglia, A A; Bagati, A A; Fink, E E EE; Moparthy, S S; Wawrzyniak, J A JA; Marvin, E K EK; Battaglia, S S; Jowdy, P P; Kolesnikova, M M; Foley, C E CE; Berman, A E AE; Kozlova, N I NI; Lipchick, B C BC; Paul-Rosner, L M LM; Bshara, W W; Ackroyd, J J JJ; Shewach, D S DS; Nikiforov, M A MA
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.
Cell Reports
Kim, Hyungsoo H; Frederick, Dennie T DT; Levesque, Mitchell P MP; Cooper, Zachary A ZA; Feng, Yongmei Y; Krepler, Clemens C; Brill, Laurence L; Samuels, Yardena Y; Hayward, Nicholas K NK; Perlina, Ally A; Piris, Adriano A; Zhang, Tongwu T; Halaban, Ruth R; Herlyn, Meenhard M MM; Brown, Kevin M KM; Wargo, Jennifer A JA; Dummer, Reinhard R; Flaherty, Keith T KT; Ronai, Ze'ev A ZA
MITF Modulates Therapeutic Resistance through EGFR Signaling.
The Journal Of Investigative Dermatology
Ji, Zhenyu Z; Erin Chen, Yiyin Y; Kumar, Raj R; Taylor, Michael M; Jenny Njauw, Ching-Ni CN; Miao, Benchun B; Frederick, Dennie T DT; Wargo, Jennifer A JA; Flaherty, Keith T KT; Jönsson, Göran G; Tsao, Hensin H
Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma models.
Molecular Cancer Therapeutics
Smyth, Tomoko T; Paraiso, Kim H T KHT; Hearn, Keisha K; Rodriguez-Lopez, Ana M AM; Munck, Joanne M JM; Haarberg, H Eirik HE; Sondak, Vernon K VK; Thompson, Neil T NT; Azab, Mohammad M; Lyons, John F JF; Smalley, Keiran S M KSM; Wallis, Nicola G NG